[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2005073404A3 - Functional element of siah-1b responsive p53 - Google Patents

Functional element of siah-1b responsive p53 Download PDF

Info

Publication number
WO2005073404A3
WO2005073404A3 PCT/IB2005/000392 IB2005000392W WO2005073404A3 WO 2005073404 A3 WO2005073404 A3 WO 2005073404A3 IB 2005000392 W IB2005000392 W IB 2005000392W WO 2005073404 A3 WO2005073404 A3 WO 2005073404A3
Authority
WO
WIPO (PCT)
Prior art keywords
functional element
siah
responsive
methods
neurodegenerative disorder
Prior art date
Application number
PCT/IB2005/000392
Other languages
French (fr)
Other versions
WO2005073404A2 (en
Inventor
Robert Amson
Adam Telerman
Original Assignee
Molecular Engines Lab
Robert Amson
Adam Telerman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Engines Lab, Robert Amson, Adam Telerman filed Critical Molecular Engines Lab
Publication of WO2005073404A2 publication Critical patent/WO2005073404A2/en
Publication of WO2005073404A3 publication Critical patent/WO2005073404A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747Apoptosis related proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A functional element of siah-lb that directly interacts with p53 is discloses. Also disclosed are methods of screening compounds useful in the treatment, prevention or management of cancer or a neurodegenerative disorder based on the interaction between p53 and the functional element, and methods of treating, preventing or managing cancer or a neurodegenerative disorder using the compounds so screened.
PCT/IB2005/000392 2004-01-29 2005-01-28 Functional element of siah-1b responsive p53 WO2005073404A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53974604P 2004-01-29 2004-01-29
US60/539,746 2004-01-29

Publications (2)

Publication Number Publication Date
WO2005073404A2 WO2005073404A2 (en) 2005-08-11
WO2005073404A3 true WO2005073404A3 (en) 2005-10-20

Family

ID=34826123

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/000392 WO2005073404A2 (en) 2004-01-29 2005-01-28 Functional element of siah-1b responsive p53

Country Status (1)

Country Link
WO (1) WO2005073404A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002002819A1 (en) * 2000-06-30 2002-01-10 University Of Utah Research Foundation Method of screening for chemotherapeutic treatments for cancer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002002819A1 (en) * 2000-06-30 2002-01-10 University Of Utah Research Foundation Method of screening for chemotherapeutic treatments for cancer

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
AMSON R B ET AL: "ISOLATION OF 10 DIFFERENTIALLY EXPRESSED CNDAS IN P53-INDUCED APOPTOSIS: ACTIVATION OF THE VERTEBRATE HOMOLOGUE OF THE DROSOPHILA SEVEN IN ABSENTIA GENE", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 93, no. 9, 30 April 1996 (1996-04-30), pages 3953 - 3957, XP002032914, ISSN: 0027-8424 *
DATABASE ENSEMBLE [online] XP002335757, retrieved from ENSEMBLE.ORG Database accession no. ENSMUSG00000040749 *
DELLA N G ET AL: "ISOLATION AND CHARACTERISATION OF MURINE HOMOLOGUES OF THE DROSOPHILA SEVEN IN ABSENTIA GENE (SINA)", DEVELOPMENT, COMPANY OF BIOLOGISTS, CAMBRIDGE,, GB, vol. 117, 1993, pages 1333 - 1343, XP000601972, ISSN: 0950-1991 *
FIUCCI GIUSY ET AL: "Siah-1b is a direct transcriptional target of p53: Identification of the functional p53 responsive element in the siah-1b promoter.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 101, no. 10, 9 March 2004 (2004-03-09), pages 3510 - 3515, XP002335752, ISSN: 0027-8424 *
MAEDA A ET AL: "The characterization of the human Siah-1 promoter<1>", FEBS LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 512, no. 1-3, 13 February 2002 (2002-02-13), pages 223 - 226, XP004341382, ISSN: 0014-5793 *

Also Published As

Publication number Publication date
WO2005073404A2 (en) 2005-08-11

Similar Documents

Publication Publication Date Title
WO2009062083A3 (en) Methods and compositions for antibody therapy
GB0513404D0 (en) Methods and systems for managing security policies
WO2005018010A8 (en) Organic electroluminescent devices having improved light extraction
GB2438133A (en) A multi-layer system for privacy enforcement and monitoring of suspicious data access behavior
DE60206490D1 (en) Dishwasher with rotatable by the Spülwasserstrom filter and crushing device
TW200705929A (en) Method and system for implementing authorization policies for web services
WO2007056388A3 (en) Compositions and methods for modulating poly (adp-ribose) polymerase activity
FR2852049B1 (en) LOCKING ASSEMBLY AND CORRESPONDING LOCK
WO2004042566A3 (en) Dynamic management of execute in place applications
WO2005115547A3 (en) Myricitrin compounds for sleeping disorders
DE50305860D1 (en) PORENBURNER AND GARGERÄT, CONTAINING AT LEAST ONE PORENBURNER
SI1620273T1 (en) Security element, such as a thread, strip and the like, for security documents in general
WO2005073404A3 (en) Functional element of siah-1b responsive p53
EP1961100A4 (en) Multi-object protection, control, and monitoring in the same intelligent electronic device
EP1643409A3 (en) Application programming Interface for Access authorization
WO2008024913A3 (en) Subscription-based private civil security resource customization method
AU2003302915A1 (en) Waste-water filter, waste-water treatment device and method incorporating the waste-water filter
AP2005003254A0 (en) Locking device and method for catch basin and manhole covers and the like.
WO2005094391A3 (en) METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING DISEASE ASSOCIATED WITH αVβ5 INTEGRIN
AU2002951987A0 (en) Security door and frame construction
WO2001051922A3 (en) Identification of peripheral benzodiazepine receptor binding agents
MX268849B (en) Polymeric materials, which contain inorganic solids, and methods for the production thereof.
WO2006103656A3 (en) Database security pre and post processor
GB0307158D0 (en) Security policy in trusted computing systems
WO2005115517A3 (en) Methods of treating diabetes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase